Skip to content
The Policy VaultThe Policy Vault

Tryngolza (olezarsen)Medica

Familial chylomicronemia syndrome

Initial criteria

  • age ≥ 18 years
  • fasting triglyceride level ≥ 880 mg/dL [documentation required]
  • Patient has undergone genetic testing and meets ONE of the following:
  • i. Molecular genetic test results demonstrate biallelic pathogenic variants in at least one gene causing familial chylomicronemia syndrome [documentation required] (genes may include LPL, GPIHBP1, APOA5, APOC2, or LMF1); OR
  • ii. Molecular genetic test results are inconclusive and the patient has ONE of the following [documentation required]:
  • a) familial chylomicronemia syndrome score ≥ 10; OR
  • b) North American familial chylomicronemia syndrome score ≥ 45; OR
  • c) history of pancreatitis; OR
  • d) history of eruptive xanthomas; OR
  • e) history of lipemia retinalis
  • Medication will be used concomitantly with a low-fat diet
  • Medication is prescribed by a cardiologist, endocrinologist, or physician specializing in severe hypertriglyceridemia

Approval duration

1 year